Microbix Biosystems Total Debt vs. Revenue
Microbix Biosystems Revenue vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Microbix Biosystems's current stock value. Our valuation model uses many indicators to compare Microbix Biosystems value to that of its competitors to determine the firm's financial worth. Microbix Biosystems is regarded third in total debt category among its peers. It is regarded fourth in revenue category among its peers totaling about 2.74 of Revenue per Total Debt. Comparative valuation analysis is a catch-all model that can be used if you cannot value Microbix Biosystems by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Microbix Biosystems' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Microbix Total Debt vs. Competition
Microbix Biosystems is regarded third in total debt category among its peers. Total debt of Health Care industry is now estimated at about 156.8 Million. Microbix Biosystems holds roughly 6.77 Million in total debt claiming about 4% of equities under Health Care industry.
Microbix Revenue vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Microbix Biosystems |
| = | 6.77 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Microbix Biosystems |
| = | 18.59 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Microbix Revenue vs Competition
Microbix Biosystems is regarded fourth in revenue category among its peers. Market size based on revenue of Health Care industry is now estimated at about 159.01 Million. Microbix Biosystems retains roughly 18.59 Million in revenue claiming about 12% of equities under Health Care industry.
Microbix Biosystems Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Microbix Biosystems, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Microbix Biosystems will eventually generate negative long term returns. The profitability progress is the general direction of Microbix Biosystems' change in net profit over the period of time. It can combine multiple indicators of Microbix Biosystems, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada. MICROBIX J is traded on Toronto Stock Exchange in Canada.
Microbix Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Microbix Biosystems. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Microbix Biosystems position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Microbix Biosystems' important profitability drivers and their relationship over time.
Microbix Biosystems Earnings per Share Projection vs Actual
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Microbix Biosystems without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Use Investing Themes to Complement your Microbix Biosystems position
In addition to having Microbix Biosystems in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Precious Metals ETFs Thematic Idea Now
Precious Metals ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Precious Metals ETFs theme has 34 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Precious Metals ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Microbix Stock
To fully project Microbix Biosystems' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Microbix Biosystems at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Microbix Biosystems' income statement, its balance sheet, and the statement of cash flows.